Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe COVID-19 Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04919031
What this trial is testing

Inspiratory Muscle Trainer and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Persistent Symptoms

Who this might be right for
Covid19HypertensionCorona Persistent Symptoms
Cairo University 90
Testing effectiveness (Phase 2)Ended earlyNCT04347226
What this trial is testing

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

Who this might be right for
Solid TumorSars-CoV2Hematological Malignancy
Columbia University 43
Not applicableStudy completedNCT04450017
What this trial is testing

Clinical Features of Severe Patients With COVID-19

Who this might be right for
SARS-CoV2
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 200
Not applicableUnknownNCT04522037
What this trial is testing

Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients

Who this might be right for
Patients Hospitalized in the Hospices Civils of LyonCOVID-19 DiseaseModerate to Severe Dyspnea+1 more
Hospices Civils de Lyon 200
Large-scale testing (Phase 3)Study completedNCT04822818
What this trial is testing

EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19

Who this might be right for
Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)Virus Diseases+5 more
Assistance Publique - Hôpitaux de Paris 96
Not applicableStudy completedNCT02788903
What this trial is testing

A Patient-Centered PaTH to Addressing Diabetes

Who this might be right for
ObesityDiabetesCovid19
Milton S. Hershey Medical Center 2,622,164
Testing effectiveness (Phase 2)Study completedNCT04830020
What this trial is testing

Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes

Who this might be right for
Covid19
Campus Bio-Medico University 180
Testing effectiveness (Phase 2)Study completedNCT04476979
What this trial is testing

Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19

Who this might be right for
Coronavirus InfectionSARS (Severe Acute Respiratory Syndrome)Virus Diseases+5 more
Assistance Publique - Hôpitaux de Paris 453
Large-scale testing (Phase 3)Ended earlyNCT05011513
What this trial is testing

Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).

Who this might be right for
COVID-19
Pfizer 1,440
Testing effectiveness (Phase 2)Study completedNCT04371367
What this trial is testing

Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )

Who this might be right for
COVID
Assistance Publique Hopitaux De Marseille 208
Not applicableStudy completedNCT04922814
What this trial is testing

Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeSedation ComplicationICU Acquired Weakness
Assiut University 40
Large-scale testing (Phase 3)Study completedNCT06585319
What this trial is testing

Pirfenidone LP or Collagen-polyvinylpyrrolidone in COVID-19

Who this might be right for
COVID 19
Materno-Perinatal Hospital of the State of Mexico 36
Not applicableStudy completedNCT04323592
What this trial is testing

Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome

Who this might be right for
Severe Acute Respiratory Syndrome (SARS) PneumoniaCoronavirus InfectionsARDS, Human
University of Trieste 173
Large-scale testing (Phase 3)Study completedNCT04817332
What this trial is testing

STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19

Who this might be right for
Covid19
University of Dundee 406
Testing effectiveness (Phase 2)Study completedNCT04347681
What this trial is testing

Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19

Who this might be right for
Convalescent Plasma for COVID 19
King Fahad Specialist Hospital Dammam 575
Early research (Phase 1)Ended earlyNCT05092581
What this trial is testing

COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 2
Not applicableUnknownNCT05019300
What this trial is testing

Long-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors.

Who this might be right for
Covid19Neurocognitive Dysfunction
Pontificia Universidad Catolica de Chile 80
Testing effectiveness (Phase 2)Study completedNCT04679415
What this trial is testing

Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia

Who this might be right for
COVID-19
ImmuneMed, Inc. 63
Not applicableStudy completedNCT06471101
What this trial is testing

Applying Artificial Intelligence to Identify Subphenotypes of Acute Kidney Injury in Mexican Patients With Severe COVID-19

Who this might be right for
COVID-19Acute Kidney Injury
Instituto Nacional de Enfermedades Respiratorias 2,934
Testing effectiveness (Phase 2)UnknownNCT05947812
What this trial is testing

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

Who this might be right for
COVID 19 DiseaseMild to Moderate COVID 19 DiseaseSARS-CoV-2+2 more
60P Australia Pty Ltd 148
Next Page